S6377
磺胺异噁唑
≥99.0%
别名:
4-氨基- N -（3,4-甲基-3-异恶唑基）苯磺酰胺, N 1 -（3,4-二甲基-5-异恶唑基）磺胺, 磺胺异恶唑
登录 查看组织和合同定价。
选择尺寸
关于此项目
经验公式（希尔记法）:
C11H13N3O3S
化学文摘社编号:
分子量:
267.30
EC Number:
204-858-9
UNSPSC Code:
12352200
PubChem Substance ID:
Beilstein/REAXYS Number:
6737262
MDL number:
assay
≥99.0%
solubility
acetone: complete 50 mg/ml, 10% HCl: complete 33 mg/mL, clear, colorless to faintly yellow, alcohol: slightly soluble, chloroform: insoluble
originator
Roche
storage temp.
2-8°C
SMILES string
Cc1noc(NS(=O)(=O)c2ccc(N)cc2)c1C
InChI
1S/C11H13N3O3S/c1-7-8(2)13-17-11(7)14-18(15,16)10-5-3-9(12)4-6-10/h3-6,14H,12H2,1-2H3
InChI key
NHUHCSRWZMLRLA-UHFFFAOYSA-N
Gene Information
rat ... Ednra(24326)
正在寻找类似产品? 访问 产品对比指南
Application
Sulfisoxazole was one of the antibiotics tested on bacterial reporter panel that gave information on pollution load on the environment.11
Biochem/physiol Actions
Sulfisoxazole, a sulfonamide, is an antibacterial agent that acts by inhibiting the folic acid metabolism.1 It is also a non-selective endothelin antagonist. It is effective in the treatment of recurrent acute otitis media and also in rendering protection to retina against ischemic-like insults.2,3
Features and Benefits
This compound was developed by Roche. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.
signalword
Warning
hcodes
Hazard Classifications
Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3
target_organs
Respiratory system
存储类别
11 - Combustible Solids
wgk
WGK 2
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
dust mask type N95 (US), Eyeshields, Gloves
法规信息
新产品
此项目有
Sahar Melamed et al.
Microbial biotechnology, 5(4), 536-548 (2012-03-06)
The ever-growing use of pharmaceutical compounds, including antibacterial substances, poses a substantial pollution load on the environment. Such compounds can compromise water quality, contaminate soils, livestock and crops, enhance resistance of microorganisms to antibiotic substances, and hamper human health. We
I Varsano et al.
American journal of diseases of children (1960), 139(6), 632-635 (1985-06-01)
The efficacy of sulfisoxazole prophylaxis was evaluated in 32 otitis-prone children in a double-blind cross-over clinical trial. During the sulfisoxazole therapy, seven patients (22%) had nine episodes of acute otitis media (AOM) while 20 patients (63%) receiving placebo had 36
Melina Mondelli et al.
Journal of inorganic biochemistry, 102(2), 285-292 (2007-11-03)
The synthesis, structural characterization, voltammetric experiments and antibacterial activity of [Ni(sulfisoxazole)(2)(H(2)O)(4)].2H(2)O and [Ni(sulfapyridine)(2)] were studied and compared with similar previously reported copper complexes. [Ni(sulfisoxazole)(2)(H(2)O)(4)].2H(2)O crystallized in a monoclinic system, space group C2/c where the nickel ion was in a slightly
Charles E Ahlfors et al.
Clinica chimica acta; international journal of clinical chemistry, 365(1-2), 78-85 (2005-09-20)
Measuring plasma unbound bilirubin concentration by the peroxidase test is useful in the management of jaundiced newborns. However, the commercially available peroxidase technology is manual, and the unbound bilirubin may be seriously underestimated at the 42-fold sample dilution and single
Hanne T Soligard et al.
Pediatric research, 67(6), 614-618 (2010-03-11)
Ibuprofen binds to plasma albumin and could interfere with the binding of bilirubin in jaundiced newborn infants. Most clinical studies have not shown increased concentrations of unbound bilirubin (UB) in plasma from infants treated with ibuprofen for a patent ductus
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持